Use of sofosbuvir in combination with ribavirin with or without pegylated interferon for the treatment of patients with hepatitis C infection genotype 4

Conclusion
Use of PEG-IFN-α with ribavirin and SOF increases the SVR more than the use of both drugs alone.

Source: Egyptian Liver Journal - January 1, 2017 Category: Gastroenterology Tags: Original articles Source Type: research